A total of 400,000 doses of the Comirnaty mRNA vaccine against COVID-19, developed by Pfizer/BioNTech, were delivered to Ukraine this month under the framework of the EU-supported COVAX Facility.
The vaccines will be distributed throughout 23 regions in the country by the Ministry of Health of Ukraine.
“With the approach of the autumn/winter period, it is especially important to protect yourself from COVID-19, because as the experience of past years shows, the incidence increases sharply at this time,” said Ihor Kuzin, Deputy Minister of Health and Chief State Sanitary Doctor of Ukraine.
Ukraine joined COVAX with the support of Team Europe, the WHO, UNICEF and other international partners. The vaccines are being delivered by the UNICEF supply department.
Find out more
News
-
EU announces €65 million pledge to support Ukraine’s school nutrition reform
-
EU boosts defence readiness with first ever financial support for common defence procurement
-
EU launches Call for EU business to invest in Ukraine’s recovery and reconstruction
-
COP29 in Baku: EU to support continued global climate action and push for ambitious finance and investment goals
-
EU and UNDP restore Serhiivskyi Lyceum in Odesa Oblast, enabling students from 12 communities to attend school in person
-
EU supports waste management project in Fastiv